Analyst Ratings February 10, 2026

Stifel Cuts ZoomInfo Price Target to $12 After Conservative Guidance; Buy Rating Stands

Analyst trims target amid cautious forward outlook even as upmarket momentum and cash generation remain strong

By Nina Shah GTM
Stifel Cuts ZoomInfo Price Target to $12 After Conservative Guidance; Buy Rating Stands
GTM

Stifel reduced its price target on ZoomInfo Technologies (NASDAQ:GTM) to $12.00 from $14.00 while keeping a Buy rating, following an earnings report that combined solid year-end trends with conservative guidance. The firm highlighted progress in the companys upmarket strategy and healthy cash flow metrics, even as the stock traded well below the new target and peers trimmed estimates and targets.

Key Points

  • Stifel cut ZoomInfo's price target to $12.00 from $14.00 but kept a Buy rating; the new target falls within an analyst range of $7-$15. (Sectors impacted: Technology, Software)
  • ZoomInfo reported solid fourth-quarter trends and stable net revenue retention, with upmarket customers (>$100,000 ACV) now representing 74% of business and upmarket growth of 6% year-over-year. (Sectors impacted: Enterprise Software, SaaS)
  • Management expanded share repurchase authorization by $1 billion, bringing total repurchase capacity to over $1.2 billion—more than half of the company's $2.05 billion market cap—while the company generated $347.8 million in levered free cash flow over the last twelve months. (Sectors impacted: Capital markets, Investor relations)

Stifel lowered its price target on ZoomInfo Technologies (NASDAQ:GTM) to $12.00 from $14.00 on Tuesday but maintained a Buy rating on the shares. The revised target remains within a wider analyst range of $7 to $15, as reported in InvestingPro data. At the time of the update, ZoomInfo was trading at $6.51, notably below Stifels target; InvestingPros Fair Value assessment nevertheless flags the stock as currently undervalued.

The analyst move followed ZoomInfos most recent quarterly release, which the firm characterized as showing solid trends exiting 2025 but accompanied by cautious forward guidance that pressured the stock in after-hours trading. Despite that conservative outlook, InvestingPro data shows 22 analysts have revised their earnings estimates higher for the upcoming period, and the company is forecast to remain profitable with an EPS projection of $1.14 for fiscal year 2025.

Stifels note emphasized ZoomInfos momentum in the upmarket segment. Customers with annual contract values exceeding $100,000 now account for 74% of the business, and management has signaled an accelerated timeline to reach an 80-20 split between upmarket and downmarket by the end of 2027. The strategic shift toward larger contracts is supported by the companys reported 87.37% gross profit margin and a free cash flow yield of 17%, according to InvestingPro figures.

Management reacted to the share price decline by expanding the share repurchase authorization by $1 billion. When combined with remaining buyback authority, the company now has repurchase capacity exceeding $1.2 billion, which represents more than half of ZoomInfos market capitalization of $2.05 billion. InvestingPro notes management has been an active buyer of shares; the stock has fallen 28.79% over the last 12 months.

Stifel kept its Buy rating despite the target reduction, pointing to expectations for continued growth in unlevered free cash flow per share driven by top-line expansion, margin improvement and the effect of ongoing share repurchases. The firm also acknowledged sector-wide multiple contraction as a headwind. ZoomInfos recent cash generation remains notable, with $347.8 million in levered free cash flow reported over the past twelve months.

ZoomInfos fourth-quarter results contributed to the mixed analyst response. The company exceeded revenue expectations by roughly 3.2% in the quarter and reported stable net revenue retention. Its upmarket business, which makes up 74% of Annual Contract Value, grew at 6% year-over-year in the quarter.

Analysts across the street have varied in their post-quarter positioning. RBC Capital reduced its target to $7.00 and kept an Underperform rating. Piper Sandler lowered its target to $8.00 and maintained a Neutral stance, noting ongoing turnaround work. DA Davidson cut its target to $7.00, citing 2026 revenue guidance that aligns with consensus expectations. Canaccord Genuity set a $12.00 target, pointing to signs of stabilization and the rollout of new products including an "AI-first workspace." Needham reaffirmed a Buy rating with a $15.00 price target, highlighting the companys robust fourth-quarter performance.

The result is a mixed set of signals for investors: positive operational indicators and strong cash conversion on one hand, and conservative near-term guidance and sector multiple pressure on the other. Stifels decision to reduce the price target while retaining a Buy reflects that balance, stressing the companys improving unit economics and active capital allocation via buybacks even as the broader sector faces valuation compression.


Contextual note: For investors seeking deeper, proprietary analysis and ProTips, InvestingPro offers an extended Pro Research Report on ZoomInfo that details the firms assessments and model assumptions.

Risks

  • Cautious forward guidance from management led to after-market pressure on the stock, indicating near-term revenue or margin uncertainty. (Sectors impacted: Technology, Software)
  • Analyst target cuts from multiple firms and sector-wide multiple compression could weigh on valuation, despite positive cash flow metrics. (Sectors impacted: Equity markets, SaaS)
  • A significant portion of market capitalization is earmarked for buybacks; if share repurchases fail to offset downward price momentum, shareholder returns may be weaker than anticipated. (Sectors impacted: Corporate finance, Capital allocation)

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026